DAMN THIS SNAP VAN YOU TRICKED ME!!! YOU SAID $70+ WHAT'S THIS CHANGE OF HEART! -LONG TIME AGO SEPT///// Ascendiant starts Atossa Therapeutics with Buy rating, $7 price target 09/17/20 ATOS Ascendiant analyst Edward Woo initiated coverage of Atossa Therapeutics with a Buy rating and $7 price target. The company has two COVID-19 drugs under development: AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation, and AT-301, a nasal spray for COVID-19 patients who are not sufficiently ill to require hospitalization, Woo tells investors in a research note. Further, Atossa's breast cancer drug under development is its proprietary form of Endoxifen, adds the analyst. Woo sees large market potential for Atossa Therapeutics.
RUN THIS THRU YOUR SYSTEM- Atossa Therapeutics raises $20M in a public offering 12/09 ATOS The securities offered by the Company consist of 14,575,000 Units, each consisting of one share of common stock, and 0.75 Warrants to purchase one share of Common Stock at a price of $1.00 per Unit and 5,425 Units, each consisting of one share of Series C Convertible Preferred Stock with a stated value of $1,000 per share and convertible into 1,000 shares of Common Stock together with Warrants to purchase 750 shares of Common Stock at a purchase price of $1,000 per Unit. The Warrants will have an exercise price of $1.00 per share, will be immediately exercisable and will expire four years from the date of issuance. Maxim Group LLC is acting as the sole book-running manager in connection with the offering.
NSDQ ATOSATOSSA THERAPEUTICS INC COM Last Price $1.3681 (+9.45%) Bid x size 1.36x 15800P Ask x size 1.37x 6300P Volume 11.00M<------------ Van you can see the stk went way down on the offering and has since roared back past!
TIME FOR A GUMMY. One thing you get pretty good at is a sense of when some hype is about to happen and I feel that way about ATOS. Van is it a go?
There it goes but is it a fake out? ATOSATOSSA THERAPEUTICS INC COM Symbol Last Price x Size / Exch $1.41 x 100C+0.1600(+12.80%)<-------
Here's my take on SNAP- They are going to beat earnings & they are my only Earnings centric play at the moment! They report maybe early Feb that's not too far away...
On etrade the ave vol for ATOS is listed at 19 mil! So today's 12 looks in line. But over on Yahoo Finance the av vol is listed at a much lower number and today's vol looks way hot....